High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Coronary Artery Disease
Interventions
DRUG

Clopidogrel

Patient will be randomized to this intervention will receive in the first time the double dose of clopidogrel and after 15 days and 30 days we will control the responsivness of the study drug.

DRUG

Prasugrel

Patient will be randomized to this intervention will receive in the first time prasugrel and after 15 days and 30 days we will control the responsivness of the study drug.

DRUG

Ticagrelor

Patient will be randomized to this intervention will receive in the first time Ticagrelor and after 14 days and 28 days we will change their therapy with the high clopidogrel dose or Prasugrel (dual crossover).

Trial Locations (1)

000161

Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT01543932 - High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients | Biotech Hunter | Biotech Hunter